Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating mindfulness-based neurofeedback to augment psychotherapy for adults with Borderline Personality Disorder; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Borderline Personality Disorder | Phase 2 | Status: RECRUITING